Podcast

Learning to Live with an Incurable, Inoperable Cancer

Author(s):

In this episode of the “CURE® Talks Cancer” podcast, author Steve Kelley shares both the painful and positive moments of his journey with a rare cancer.

Steve Kelley is a professor, public speaker, grandfather and avid biker, among other things. But he is also living with central nervous system lymphoma, a rare cancer that his doctors told him is incurable and inoperable.

After being unable to find peers facing a similar diagnosis, Kelley decided to share his story in the book, “Cancer R.I.P.: The Ultimate Fight.”

In this episode of the “CURE® Talks Cancer” podcast, Kelley opens up about his cancer journey and offers others advice on how to get through life after receiving such a shattering diagnosis.

“If you can try to do (these) four things, M-A-T-H, do the math: meaning, action, trust and hope,” Kelley said. “You can do those things for the people in your life and for yourself. I think that will put you in this great place that enables you to couple that with grace, couple that with exercise, and now you're in a place that you can do the best you can with cancer.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with a brown hair tied into a bun.
Related Content